» Articles » PMID: 2670849

Development and Validation of a Sensitive Immunohistochemical Oestrogen Receptor Assay for Use on Archival Breast Cancer Tissue

Overview
Journal Histochemistry
Specialty Biochemistry
Date 1989 Jan 1
PMID 2670849
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

In a preliminary paper (Teasdale et al. 1987) comparing the oestrogen receptor (ER) content of breast cancers by the biochemical dextran coated charcoal (DCC) method and by two histochemical methods, peroxidase immunocytochemistry (ERICA) and immunogold-silver staining (IGSS), it was indicated that ERICA is more sensitive than DCC and that IGSS is as specific as ERICA but less sensitive. This paper describes the comparison of the above three assay methods with two other biochemical methods, iso-electric focusing (IEF) and an enzyme immuno-assay (EIA) on a larger number of cancers. All methods gave statistically comparable results except that IGSS remained less sensitive than the rest. Various modifications to IGSS showed that an immunogold streptavidin enhancement method (IG-SAM) produced sensitivity and specificity equal to that of ERICA. Since IGSS and its modifications are the only methods which can be used on archival paraffin-embedded cancers and IG-SAM gives results highly comparable to ERICA, retrospective studies can be performed on patients whose outcome and response to various treatments are known. Most recent studies have shown that ER positive results can be obtained from 10-year-old paraffin blocks.

Citing Articles

Predicting aggressive outcome in T1N0M0 breast cancer.

Kronqvist P, Kuopio T, Nykanen M, Helenius H, Anttinen J, Klemi P Br J Cancer. 2004; 91(2):277-81.

PMID: 15199391 PMC: 2409808. DOI: 10.1038/sj.bjc.6601948.


Ultrastructural localisation of oestrogen receptor in breast cancer cell nuclei.

Walsh P, Teasdale J, Cowen P Histochemistry. 1990; 95(2):205-7.

PMID: 2081695 DOI: 10.1007/BF00266594.


Classical oestrogen receptor is not detectable in pancreatic adenocarcinoma.

TAYLOR O, Teasdale J, Cowen P, McMahon M, Benson E Br J Cancer. 1992; 66(3):503-6.

PMID: 1520587 PMC: 1977934. DOI: 10.1038/bjc.1992.303.

References
1.
Holgate C, Jackson P, LAUDER I, Cowen P, Bird C . Surface membrane staining of immunoglobulins in paraffin sections of non-Hodgkin's lymphomas using immunogold-silver staining technique. J Clin Pathol. 1983; 36(7):742-6. PMC: 498380. DOI: 10.1136/jcp.36.7.742. View

2.
McGuire W, Clark G . The prognostic role of progesterone receptors in human breast cancer. Semin Oncol. 1983; 10(4 Suppl 4):2-6. View

3.
Wittliff J . Steroid-hormone receptors in breast cancer. Cancer. 1984; 53(3 Suppl):630-43. DOI: 10.1002/1097-0142(19840201)53:3+<630::aid-cncr2820531308>3.0.co;2-3. View

4.
Holgate C, Jackson P, Cowen P, Bird C . Immunogold-silver staining: new method of immunostaining with enhanced sensitivity. J Histochem Cytochem. 1983; 31(7):938-44. DOI: 10.1177/31.7.6189883. View

5.
Williams M, Todd J, Ellis I, Dowle C, Haybittle J, Elston C . Oestrogen receptors in primary and advanced breast cancer: an eight year review of 704 cases. Br J Cancer. 1987; 55(1):67-73. PMC: 2001565. DOI: 10.1038/bjc.1987.14. View